Filip Van Herpe

5PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2026
Perioperative FLOT chemotherapy for locally advanced esophageal adenocarcinoma: from ESOPEC to daily practice-a retrospective cohort study.

|Jul 11, 2026
Real-world feasibility and safety of neoadjuvant FOLFIRINOX in pancreatic ductal adenocarcinoma: a retrospective single-center study.

|Feb 05, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

Ylva A Weeda, Roberto Salgado, Filip van Herpe

|Dec 30, 2025
Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges.

Justine Maes, Bernard Pôlet, Janke Kleynhans

|Oct 11, 2024
Salvage Surgery for Unifocal Progressive Metastatic Mismatch Repair-Deficient GI Cancer Responding to Immune Checkpoint Inhibition.

Pieterjan Perremans, Filip Van Herpe, Gertjan Rasschaert

Pageof 1

Frequent Collaborators

3 joint publications

Jeroen Dekervel

2 joint publications

Baki Topal

2 joint publications

Philippe Nafteux

1 joint publications

Gabriele Bislenghi